Viral vaccine trains body to fight advanced cancers
NCT ID NCT01147965
Summary
This early-stage study tested a new cancer vaccine designed to teach the body's immune system to recognize and attack tumors. It involved 43 people with advanced colorectal, lung, breast, or prostate cancer that had stopped responding to standard treatments. The main goals were to check the vaccine's safety and see if it triggered a strong immune response against the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke Cancer Research Institute, Duke University
Durham, North Carolina, 27710, United States
-
Medical Oncology Associates, PS
Spokane, Washington, 99208, United States
Conditions
Explore the condition pages connected to this study.